The first is conflating injectable and topical dosing conventions applying an injectable milligram-target approach to a topical protocol that should use concentration-based formulation, or vice versa
Thus, it was likely that after tail amputation in rats, with/out heparin and warfarin administration, BPC 157 would counteract the consequences of administration of the NOS-blocker, L-NAME (i.e., prothrombotic effect and thereby thrombocytopenia) and/or NOS-substrate, L-arginine (i.e., antithrombotic effect and thereby more bleeding) [2931]
Consider complementary NAD+ precursors (NMN/NR) per emerging stack protocols
Youll leave feeling informed, motivated, and excited to experience the boost your body deserves
BPC-157 is a synthetic 15-amino-acid peptide based on a partial sequence of Body Protection Compound, a protein originally isolated from human gastric juice
Additionally, some individuals may experience a brief sensation of dizziness or lightheadedness immediately after the injection, which usually resolves quickly